55 Stocks Moving In Friday's Mid-Day Session

Gainers

• Verona Pharma plc VRNA shares surged 154% to $12.24 after the company announced it raised $200 million in a private placement at $4.50 per share.
• RumbleON, Inc. RMBL shares jumped 95% to $20.89 after the company reported a dealer-centric pilot program with CarGurus.
• ALX Oncology Limited ALXO gained 87% to $35.51 after the company priced its 8.5 million share IPO at $19 per share.
• Applied DNA Sciences, Inc. APDN shares climbed 36.7% to $12.29 following the release of positive preclinical data for its partnered coronavirus vaccine candidate. The company said linear-DNA forms of COVID-19 vaccine candidates being developed by partner Takis Biotech and manufactured by Applied DNAyielded strong antibody and T-cell responses even at very low doses, raising the potential of effective dosing empowering global utility.
• Ocwen Financial Corporation OCN gained 31.3% to $0.85 after the company reported net income of $2 million for the three months ended June 30, 2020.
• Vaccinex Inc VCNX climbed 30.6% to $7.40 after Point72 Asset Management disclosed a 7.2% passive stake in the company in a Thursday filing.
• Houghton Mifflin Harcourt Company HMHC rose 30.2% to $3.035. Houghton Mifflin Harcourt responded to 'false rumors' on Twitter regarding new sales contracts.
• ClearPoint Neuro, Inc. CLPT gained 28% to $4.6329.
• PDS Biotechnology Corporation PDSB gained 27.4% to $3.185.
• Houghton Mifflin Harcourt Company HMHC rose 26% to $2.9601. Houghton Mifflin Harcourt shares jumped 32% on Thursday after the company introduced Teacher's Corner, a brand new online space supporting professional learning for educators.
• Heat Biologics, Inc. HTBX rose 25.7% to $2.4758 after jumping 35% on Thursday.
• Bionano Genomics, Inc. BNGO rose 24.6% to $0.6480 after the company said that the “first ever complete assembly of a human chromosome utilized its genome imaging technology to assemble the genome correctly and verify the accuracy.”
• OptiNose, Inc. OPTN gained 24.4% to $6.01.
• Daxor Corporation DXR shares surged 24.4% to $22.38. On Thursday, Daxor announced the initiation of a prospective randomized control trial to guide volume treatment in heart failure patients..
• Barnes & Noble Education, Inc. BNED rose 22.3% to $2.6910. Barnes & Noble Education reported mixed quarterly results on Tuesday.
• Tenax Therapeutics, Inc. TENX shares rose 21.5% to $1.2999 after Armistice Capital reported a 19.99% active stake in the company.
• MicroVision, Inc. MVIS shares rose 21% to $2.82 after climbing around 23% on Thursday.
• AutoWeb, Inc. AUTO rose 19.1% to $1.56 following a 10% surge on Thursday.
• Dynavax Technologies Corporation DVAX gained 19% to $11.29. Dynavax on Thursday reported collaboration with Mount Sinai to develop a universal flu vaccine candidate with CpG 1018 adjuvant.
• Five Prime Therapeutics, Inc. FPRX shares rose 17.2% to $7.23.
• INmune Bio, Inc. INMB gained 16.8% to $12.52. INmune Bio share dropped 18% on Thursday after reporting a proposed public offering of common stock.
• Evolent Health, Inc. EVH climbed 16.6% to $9.89. Evolent Health disclosed that Molina Healthcare, Inc. and Passport Health Plan have entered into a definitive agreement for Molina to buy certain assets of Passport.
• The Peck Company Holdings, Inc. PECK gained 16.5% to $4.94.
• Novavax, Inc. NVAX rose 16% to $139.46 following a media report that the European Union is in discussion with several coronavirus vaccine companies to secure doses of a vaccine.
• Natural Grocers by Vitamin Cottage, Inc. NGVC shares gained 16% to $15.70.
• Ideal Power Inc. IPWR shares jumped 15% to $7.85.
• SenesTech, Inc. SNES gained 15% to $2.60.
• DiaMedica Therapeutics Inc. DMAC shares surged 14.8% to $7.29.
• Rosetta Stone Inc. RST shares gained 14.3% to $18.29.
• AcelRx Pharmaceuticals, Inc. ACRX rose 14% to $1.2201 after the company won a $3.5 million US Army medical research acquisition contract for Dsuvia.
• OPKO Health, Inc. OPK gained 13% to $4.5527.
• Telefonaktiebolaget LM Ericsson ERIC rose 12.9% to $10.85 after reporting Q2 results.
• Blink Charging Co. BLNK rose 12% to $6.64.
• Crestwood Equity Partners LP CEQP rose 11.6% to $13.74. Crestwood Equity Partners declared a quarterly cash distribution of $0.625 per limited partner unit.
• Nabriva Therapeutics plc NBRV rose 11.5% to $0.9365 after the company reported that its partner Sunovion Pharmaceutical Canada has received approval from the Health Canada to market its oral and intravenous formulations of XENLETA.
• Medigus Ltd. MDGS gained 10.9% to $1.85 after the company announced it will resell Polyrizon's future products for 'protection against COVID-19 spread and other biological threats.'
• PhaseBio Pharmaceuticals Inc PHAS rose 10.8% to $5.21 after the company disclosed that it has dosed the first patient in VANGUARD, a Phase 2 clinical trial evaluating PB1046 as a treatment for Covid-19 patients.
• Inovio Pharmaceuticals, Inc. INO climbed 9.1% to $26.81 due to continued vaccine optimism.
• MeiraGTx Holdings PLC MGTX gained 7% to $13.09 after the company issued a positive data update on its Phase 1/2 clinical trial for retinitis pigmentosa..
• Foresight Autonomous Holdings Ltd. FRSX surged 6.4% to $1.6599 after the company announced it will begin a pilot project for its prototype COVID-19 symptom detection mass screening solution.

Check out these big penny stock gainers and losers

Losers

• Aehr Test Systems AEHR shares dipped 20.5% to $1.9403 after the company reported weaker-than-expected Q4 revenue.
• Boxlight Corporation BOXL declined 16.9% to $3.49. Boxlight shares jumped over 76% on Thursday after the company's website discussed a collaboration with Samsung.
• Itau Corpbanca ITCB fell 15% to $4.50 after climbing 32.3% on Thursday. Itau Corpbanca is expected to release Q2 earnings on August 3, 2020.
• NIO Inc. NIO dropped 14.7% to $11.04 after Goldman Sachs downgraded the stock from Neutral to Sell and announced a $7 price target.
• Capitala Finance Corp. CPTA shares declined 13.4% to $2.58.
• J.Jill, Inc JILL fell 11.6% to $0.7688. J. Jill shares jumped 38% on Thursday after the company announced the extension of a forbearance agreement with lenders.
• Cytokinetics, Incorporated CYTK fell 10% to $23.15 after the company priced its 7.3 million share common stock offering at $24 per share.
• SINTX Technologies Inc SINT dropped 9.8% to $2.0466 after the company priced its 1.5 million share offering at $2 per share.
• Nxt-ID, Inc. NXTD fell 9.7% to $0.4201 after rising 9% on Thursday.
• SCYNEXIS, Inc. SCYX shares declined 7.9% to $5.72. On Thursday, SCYNEXIS reported a 1-for-10 reverse stock split.
• Equillium, Inc. EQ shares fell 7.6% to $13.65 after dropping 15% on Thursday.
• InflaRx N.V. IFRX shares declined 7.3% to $5.07.
• BIO-key International, Inc. BKYI slipped 7.1% to $1.1150. BIO-Key International shares jumped over 50% on Thursday after California's North Orange County Community College District implemented the company's
• PortalGuard.
• Netflix, Inc. NFLX fell 6.7% to $492.07 after the company reported mixed results for its second quarter. Netflix issued weak outlook for new subscriber additions and also named 20-year Netflix veteran Ted Sarandos to the role of co-CEO alongside co-founder Reed Hastings. Credit Suisse downgraded Netflix from Outperform to Neutral and lowered the price target from $550 to $525.
• AC Immune SA ACIU fell 5% to $8.14. AC Immune shares jumped 19% on Thursday on Alzheimer's trial update from the company.